<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND &amp; AIMS: Neoadjuvant chemotherapy prior to liver surgery for colorectal <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastases</z:e> can cause marked <z:hpo ids='HP_0001397'>steatosis</z:hpo> (≥ 33%) and steatohepatitis defined by non-alcoholic <z:hpo ids='HP_0001397'>fatty liver</z:hpo> disease activity score (NAS) as adverse effects on liver parenchyma </plain></SENT>
<SENT sid="1" pm="."><plain>The aim of this study was to evaluate the <z:hpo ids='HP_0001397'>steatosis</z:hpo> level prior to liver resection using proton magnetic resonance spectroscopy ((1)H MRS) and to compare it with digital quantification of <z:hpo ids='HP_0001397'>steatosis</z:hpo> (DQS) and "classical" histopathology </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: (1)H MRS at 3T evaluated <z:hpo ids='HP_0001397'>steatosis</z:hpo> in 35 patients with colorectal <z:e sem="disease" ids="C0494165" disease_type="Neoplastic Process" abbrv="">liver metastasis</z:e>, planned for liver resection </plain></SENT>
<SENT sid="3" pm="."><plain>Non-tumorous liver parenchyma samples were obtained after surgery for classical histopathology and DQS utilising automated software for quantification of histopathological slides using image processing </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: Classical histopathology defined marked <z:hpo ids='HP_0001397'>steatosis</z:hpo> in nine patients </plain></SENT>
<SENT sid="5" pm="."><plain>Histopathology was less reliable than DQS (interclass correlation coefficient - <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICC</z:e> 0.771) or (1)H MRS (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICC</z:e> 0.722) in <z:hpo ids='HP_0001397'>steatosis</z:hpo> estimation </plain></SENT>
<SENT sid="6" pm="."><plain>(1)H MRS showed very similar <z:hpo ids='HP_0001397'>steatosis</z:hpo> levels and high reliability compared to DQS (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICC</z:e> 0.955) </plain></SENT>
<SENT sid="7" pm="."><plain>Steatohepatitis was observed in seven patients (NAS ≥ 4) and (1)H MRS was able to predict it with 100% sensitivity and 89% specificity at threshold 10.9%, without knowing lobular <z:mp ids='MP_0001845'>inflammation</z:mp> or hepatocyte ballooning </plain></SENT>
<SENT sid="8" pm="."><plain>BMI was significantly higher in the groups with marked <z:hpo ids='HP_0001397'>steatosis</z:hpo> and steatohepatitis </plain></SENT>
<SENT sid="9" pm="."><plain>Standard blood tests or chemotherapy had no predictive value </plain></SENT>
<SENT sid="10" pm="."><plain>CONCLUSIONS: (1)H MRS is a reliable non-invasive tool for <z:hpo ids='HP_0001397'>steatosis</z:hpo> assessment, and interestingly, it was able to predict steatohepatitis defined by NAS ≥ 4 in patients planned for liver resection of colorectal <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastases</z:e> after neoadjuvant chemotherapy </plain></SENT>
</text></document>